Controlled release lipoic acid

Details Controlled release lipoic acid Controlled release lipoic acid

2006-10-10

2006-10-10

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S451000, C424S452000, C424S457000, C424S463000, C424S464000, C424S465000, C424S474000, C424S475000, C424S489000, C424S490000, C424S400000

Reexamination Certificate

active

07118762

ABSTRACT:
A controlled release formulation of lipoic acid is disclosed. The lipoic acid is combined with excipient materials in such a way that those materials provide for gradual release of the lipoic acid in a manner which makes it possible to substantially increase the period of time over which therapeutic levels of lipoic acid are maintained relative to a quick release formulation. These features make it possible to use lipoic acid to reduce serum glucose levels and maintain those levels over time thereby obtaining a range of desired therapeutic results.

REFERENCES:
patent: 3577551 (1971-05-01), Murakami et al.
patent: 4389393 (1983-06-01), Schor et al.
patent: 4461759 (1984-07-01), Dunn
patent: 4520009 (1985-05-01), Dunn
patent: 4540566 (1985-09-01), Davis et al.
patent: 4556678 (1985-12-01), Hsiao
patent: 4705867 (1987-11-01), Giray et al.
patent: 4800044 (1989-01-01), Giray et al.
patent: 4966732 (1990-10-01), Giray et al.
patent: 5334612 (1994-08-01), Kalden et al.
patent: 5376382 (1994-12-01), Goede et al.
patent: 5393765 (1995-02-01), Infeld et al.
patent: 5455264 (1995-10-01), Beisswenger et al.
patent: 5505962 (1996-04-01), Sparks
patent: 5527539 (1996-06-01), Sarlikiotis et al.
patent: 5532269 (1996-07-01), Koltringer
patent: 5569670 (1996-10-01), Weischer et al.
patent: 5599835 (1997-02-01), Fischer
patent: 5616345 (1997-04-01), Geoghegan et al.
patent: 5637320 (1997-06-01), Bourke et al.
patent: 5641515 (1997-06-01), Ramtoola
patent: 5641745 (1997-06-01), Ramtoola
patent: 5650429 (1997-07-01), Conrad et al.
patent: 5691379 (1997-11-01), Ulrich et al.
patent: 5693664 (1997-12-01), Wessel et al.
patent: 5705192 (1998-01-01), Bethge et al.
patent: 5728735 (1998-03-01), Ulrich et al.
patent: 5730988 (1998-03-01), Womack
patent: 6191162 (2001-02-01), Byrd et al.
patent: 6197340 (2001-03-01), Byrd et al.
patent: 6572888 (2003-06-01), Byrd
patent: 1 668 887 (1971-07-01), None
patent: 36 29 116 (1988-03-01), None
patent: 42 20 851 (1993-01-01), None
patent: 43 17 646 (1994-12-01), None
patent: 43 38 508 (1995-05-01), None
patent: 43 43 592 (1995-06-01), None
patent: 43 43 647 (1995-06-01), None
patent: 44 00 269 (1995-07-01), None
patent: 44 47 599 (1996-07-01), None
patent: 0 109 320 (1986-06-01), None
patent: 0 111 144 (1986-12-01), None
patent: 0 159 519 (1987-02-01), None
patent: 0 702 953 (1995-08-01), None
patent: 0 733 363 (1996-03-01), None
patent: 0 712 574 (1996-10-01), None
patent: 60-184011 (A) (1985-09-01), None
patent: WO 95/31994 (1995-11-01), None
patent: WO 98/57627 (1998-12-01), None
Guillausseau, PJ, “Preventative Treatment of Diabetic Microangiopathy: blocking the pathogenic mechanisms,”Diabete Metab.20(2 Pt. 2): 219-28 (1994).
Jacob et al., “Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid”Exp. Clin. Endocrinol. Diabetes104(3):294-8 (1996).
Jacob et al., “Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid”Arzneimittelforschung45(8):872-4 (Aug. 1995).
Kahler et al., “Diabetes mellitus—a free radical-associated disease. Results of adjuvant antioxidant supplementation”Z Gesamte Inn Med48(5):223-32 (May 1993).
Shih, Jason C.H., “Atherosclerosis in Japanese quail and the effect of lipoic acid”Avian Models for Research in Atherosclerosis and Cholesterol42(8):2494-2497 (May 15, 1983).
“Andrx to File Seven to 10 ANDAs for Controlled Release Generics,”The Tan Sheet, 2(15):21 (Apr. 11, 1994).
“Sunsource Melatonex debuts with $6 mil. Ad support; Par, Rexall unveil melatonin products.”The Tan Sheet4(13):9 (Mar. 25, 1996).
“Dietary Supplement Statements of Nutritional Support”The Tan Sheet, 4(18):1 (Apr. 29, 1996).
“Phenylpropanolamine 75 mg Controlled-Release Daily Dosage Form is Effective”The Tan Sheet, 2(22):1 (May 30, 1994).
“La Haye Labs”The Tan Sheet, 2(27):21 (Jul. 4, 1994).
“Controlled-release niacin”The Tan Sheet, 2(36):25 (Sep. 5, 1994).
“Syntex' EC-Naprosyn”The Tan Sheet, 2(44):30 (Oct. 31, 1994).
“Schiff, Rexall Sundown enter whole-food phytonutrients market in Jun.”The Tan Sheet, 3(28):5 (Jul. 10, 1995).
“Pharmaceutical Resources launching Nutraceutical Resources in melatonin line in Mar.”The Tan Sheet, 4(8):18 (Feb. 19, 1996).
“Dietary Supplement Statements of Nutrional Support”The Tan Sheet, 4(31):1 (Jul. 29, 1996).
“Dietary Supplement Statments of Nutritional Support”The Tan Sheet, 4(39):1 (Sep. 23, 1996).
“In Brief: Natrol”The Tan Sheet, 4(17):21 (Apr. 22, 1996).
“Bock Prenate Ultra touted for lower toxicity in cases of accidental ingestion”The Tan Sheet, 4(35):10 (Aug. 26, 1996).
“Leiner folate
eural tube defect claim subject of FDA “courtesy letter””The Tan Sheet, 5(2):1 (Jan. 13, 1997).
“Ascent Pediatrics acetaminophen controlled-release beads NDA expected by end of 1997”The Tan Sheet, 5(19):13 (May 12, 1997).
Armstrong et al.,Free Radical Biology and Chemistry, (1996) 21(5):719-726.
Barbiroli et al.,J Neurol, (1995) 242:472-477.
Baur et al.,Klin Wochenschr, (1991) 69:722-724.
Bilich et al.,I-Pharmacodynamics, (1978) 88:93.
Black et al.,Clinical and Experimental Pharmacology and Physiology, (1998) 25:712-714.
Bloomgarden,Diabetes Care, (Apr. 1997) 20(4):670-673.
Burkart et al.,Agents Actions(1993) 38:60-65.
Busse et al.,Arzneim-Forsch/Drug Research(1992) 42(6):829-831.
Bustamante et al.,Free Radical Biology and Medicine, (1998) 24(6):1023-1039.
Carreau,Methods in Enzymology, (1979) 62:152-158.
Cesolari et al.,Rev Exp Erif Ap Digest, (1988) 73(3) 229-232.
Chen et al.,Archives of Biochemistry and Biophysics, (1997) 338(2):165-172.
Devasgayam et al.,Chem-Biol Interactions, (1993) 86:79-92.
Dimpfel et al.,Dev Pharmacol Ther, (1990) 14:193-199.
Egan et al.,Prostaglandins, (1978) 16(6):861-869.
Estrada et al.,Diabetes, (Dec. 1996) 45:1498-1804.
Faust et al.,J Immunopharmac, (1994) 16(1):61-66.
Fuchs et al.,Skin Pharmacol, (1994) 7:278-284.
Gandhi et al.,J Biosci(Sep. 1985) 9(1 & 2):117-127.
Garrett et al.,Neuroscience Letters, (1997) 222:191-194.
Gerbitz et al.,Diabetes, (Feb. 1996) 45:113-126.
Hammarqvist et al.,Crit Care Med, (1997) 25(1):78-84.
Haugaard et al.,Biochem Biophys Acta, (1970) 222:583-586.
Henricksen et al.,American Physiological Society, (1990) C648-C653.
Henricksen et al.,Life Sciences(1997) 61(8):805-812.
Hofmann et al.,Archives of Biochemistry and Biophysics(1995) 324(1):85-92.
Jacob et al.,Diabetes, (1995) 245-250.
Jacob et al.,Diabetes(Aug. 1996) 45:1024-1029.
Kagan et al.,Biochemical Pharmacology(1992) 44(8): 1637-1649.
Kagan et al.,Journal of Lipid Research, (1992) 33:385-397.
Kagan et al.,Free Rad Res Comms, (1991) 15(5):265-276.
Khamaisi et al.,Metabolism, (Jul. 1997) 45(7):763-768.
Lavis et al.,The Journal of Biologic Chemistry, (Jan. 110, 1970) 245(1):23-31.
Lodge et al.,Journal of Applied Nutrition, (1997) 49 (1 & 2)3-11.
Lodge et al.,Free Radical Biology&Medicine, (1998) 25(3):287-297.
Matsugo et al.,Biochemistry and Molecular Biology International, (Oct. 1995) 37(2)375-383.
Merin et al.,FEBS Letters, (1996) 294:9-13.
Muller at al.,Toxicology(1989) 58:175-185.
Muller et al.,Biochimica et Biophysica Acta, (1990) 1052:386-389.
Muller et al.,Journal of Cerebral Blood Flow and Metabolism, (1995) 15:624-630.
Nagamatsu et al.,Diabetes Care, (1995) 18(8):1160-1167.
National Diabetes Data Group Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance,Diabetes(1979) 28:1039-1057.
Natraj et al.,J. Biosci, (1984) 6(1):38-46.
Nickander et al.,Free Radical Biology&Medicine(1996) 21(5): 631-639.
Ohmori et al.,Japan J. Pharmacol, (1986) 42:275-2.
Ohmori et al.,Japan J. Pharmacol, (1986) 42:135-140.
Ou et al.,Free Rad Res, (1996) 25(4):337-346.
Ou et al.,Biochemial Pharmacology, (1995) 50(1):123-126.
Packer et al.,Free Radical Biology&Medicine, (1997) 22(1/2):359-378.
Packer

Affiliated with

Also associated with

Rating

Controlled release lipoic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release lipoic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release lipoic acid will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3688649